Home » Newsletters » BioWorld Science

BioWorld Science

July 13, 2016

View Archived Issues

Servier gains worldwide license to Sorrento's anti-PD-1 antibody

Launch of the Human Cancer Models Initiative

EGCG with cognitive training shows beneficial effects for Down syndrome

Biocad's bispecific MAb shows promise for rheumatoid arthritis in preclinical studies

Amgen initiates first-in-human study of AMG-176 in multiple myeloma

Bayer and X-Chem expand global collaboration for drug discovery in areas of high unmet medical need

BerGenBio patents PKB gamma inhibitors

Forendo Pharma discloses 17beta-HSD1 inhibitors

Seres Therapeutics announces collaboration with Emulate

FDA lifts clinical hold on ROCKET study of JCAR-015

Jazz Pharmaceuticals gives update on acquisiton of Celator Pharmaceuticals

Emory University develops compounds for HBV infections

Pfizer presents prostanoid EP3 receptor antagonists

Seqirus ships seasonal influenza vaccines for the U.S. market

FDA approves Kovanaze nasal spray for dental anesthesia

Roivant Sciences and Plexcera announce formation of Enzyvant Sciences

Murine model of Zika virus disease developed at UTMBHealth

Positive topline results from phase II study of SAGE-547 in severe postpartum depression

Roche Diagnostics and Spanish partners to codevelop NNGS platform

In vitro and in vivo efficacy of novel antimicrobial agent with a dual mechanism of action

EMA committee recommends orphan drug designation for Akari's Coversin

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...